| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO And Chairman Of The Board | Chief Scientific Officer +1 more
1 company
Neil Garry Arthur is a Chief Executive Officer at AVTX. Recent filings cover 6 purchases and 0 sales.
Our model assigns Neil Garry Arthur a below-average insider score of 11/100, based on 4 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -90.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | AVTX Avalo Therapeutics, Inc. | CEO And Chairman Of The Board | Buy | 4,000 | $3.42 | $13,680.00 | +43.4% | -97.6% | -98.9% | |
| Dec 9, 2022 | AVTX Avalo Therapeutics, Inc. | CEO And Chairman Of The Board | Buy | 2,083 | $4.42 | $9,206.86 | +29.2% | -53.5% | -99.0% | |
| Dec 10, 2021 | AVTX Avalo Therapeutics, Inc. | Chief Scientific Officer | Buy | 4,267 | $1.57 | $6,699.19 | +5.2% | -61.9% | -76.6% | |
| Jun 10, 2021 | AVTX Avalo Therapeutics, Inc. | Chief Scientific Officer | Buy | 3,692 | $2.28 | $8,417.76 | +4.8% | -22.9% | -87.0% | |
| Dec 10, 2020 | AVTX Avalo Therapeutics, Inc. | Chief Scientific Officer | Buy | 3,599 | $2.28 | $8,198.52 | +4.9% | - | - | |
| Jun 10, 2020 | AVTX Avalo Therapeutics, Inc. | Chief Scientific Officer | Buy | 1,799 | $2.28 | $4,098.12 | +2.5% | - | - |